Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

Better Coronavirus Stock: Moderna vs. Sorrento Therapeutics

One successful coronavirus vaccine or therapy could translate to a lot of revenue in a relatively short period of time. Investors seeking this explosive growth have flocked to both Moderna (NASDAQ: MRNA) and Sorrento Therapeutics (NASDAQ: SRNE). Both biotech stocks have soared, thanks to key developments with their respective COVID-19 programs.